Publication | Open Access

Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)

Medicinal ChemistryBiochemistryMedicineNatural SciencesReceptor Tyrosine KinaseAnti-cancer AgentWarburg EffectPharmacologyInhibitory ActivityCancer ResearchDrug Discovery